Dr. Zhou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 South Rd
Ste 200
Farmington, CT 06032Phone+1 269-424-1133
Summary
- I received my MD and PhD degrees from the University of Maryland School of Medicine. I am currently a dermatology resident at the University of Connecticut. In my spare time, I enjoy exercising and exploring new restaurants/cuisines. I am a 2022-2023 Doximity Luminary Fellow.
Clinical Expertise
- Seborrheic keratosis, Blistering diseases, Lupus erythematosus, Basal cell carcinoma, Squamous cell carcinoma, Hidradenitis suppurativa, Melanoma, Albinism, Dermatology, Internal medicine
Education & Training
- University of ConnecticutResidency, Dermatology, 2022 - 2026
- University of MarylandInternship, Internal Medicine, 2022 - 2023
- University of Maryland School of MedicineClass of 2022
Certifications & Licensure
- CT State Medical License 2023 - 2026
- MD State Medical License 2023 - 2024
Publications & Presentations
PubMed
- Ethical Issues of Dermatologic Medical Tourism.Seda Sahin, Albert E Zhou, Jane M Grant-Kels
Journal of the American Academy of Dermatology. 2024-12-13 - Navigating the Ethical and Legal Complexities of Medical Marijuana Use in Dermatology.Humza Zaidi, Albert E Zhou, Jane M Grant-Kels, Campbell L Stewart, Jun Lu
Journal of the American Academy of Dermatology. 2024-12-03 - Case of recalcitrant amyopathic dermatomyositis treated with upadacitinib.Albert E Zhou, Maria Katsetos, Jun Lu
JAAD Case Reports. 2024-12-01
Authored Content
- Appreciating patients as unique individuals makes us better physiciansJanuary 2022
Press Mentions
- A Day in the LifeNovember 3rd, 2023
- Improving the Quality of Life for Patients With AlbinismJuly 26th, 2023
- Children not getting ‘essential’ sickle cell treatment in sub-Saharan AfricaAugust 27th, 2022
- Join now to see all
Grant Support
- The role of RIFINs and their interaction with blood type in vulnerability to severe malaria in Malian childrenNational Heart Lung and Blood Institute (NHLBI)2019–2022
Professional Memberships
- Member
- Member
- Gold Humanism Honors SocietyMember
External Links
- Linktreehttps://linktr.ee/albertzhou
- Med School Insidershttps://medschoolinsiders.com/our-team/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: